RESEARCHING A POTENTIAL NEW WAY TO HELP PEOPLE WITH COPD
JOIN A CLINICAL STUDY TO HELP US RESEARCH AN INVESTIGATIONAL MEDICATION FOR COPD
The RPL554-CO-302 Study is looking at a potential new medication (investigational medication) to see how safe it is and whether it works for people with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD). The study will help us learn whether the investigational medication is able to reduce swelling and widen the airways of the lungs in a single medication.
You may be able to take part if you:
- are 40–80 years of age
- have been diagnosed with COPD
- have been, or currently are, a cigarette smoker
The RPL554-CO-302 Study will last for up to 30 weeks. All study medication and study-related care will be provided at no cost to you.
To learn more, please contact the study team:
Center for Clinical Trials
of Sacramento, Inc
7600 Hospital Drive
Sacramento, CA 95823
The RPL554–CO–302 Study